Your browser doesn't support javascript.
loading
Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor.
Van den Bossche, J; Lardon, F; Deschoolmeester, V; De Pauw, I; Vermorken, J B; Specenier, P; Pauwels, P; Peeters, M; Wouters, A.
Affiliation
  • Van den Bossche J; Center for Oncological Research (CORE) Antwerp, University of Antwerp, Antwerp, Belgium.
  • Lardon F; Center for Oncological Research (CORE) Antwerp, University of Antwerp, Antwerp, Belgium.
  • Deschoolmeester V; Center for Oncological Research (CORE) Antwerp, University of Antwerp, Antwerp, Belgium.
  • De Pauw I; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.
  • Vermorken JB; Center for Oncological Research (CORE) Antwerp, University of Antwerp, Antwerp, Belgium.
  • Specenier P; Center for Oncological Research (CORE) Antwerp, University of Antwerp, Antwerp, Belgium.
  • Pauwels P; Department of Oncology, Antwerp University Hospital, Edegem, Belgium.
  • Peeters M; Center for Oncological Research (CORE) Antwerp, University of Antwerp, Antwerp, Belgium.
  • Wouters A; Department of Oncology, Antwerp University Hospital, Edegem, Belgium.
Med Res Rev ; 36(4): 749-86, 2016 07.
Article in En | MEDLINE | ID: mdl-27140825
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pteridines / Proto-Oncogene Proteins / Protein Serine-Threonine Kinases / Cell Cycle Proteins / Protein Kinase Inhibitors / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Animals / Humans Language: En Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pteridines / Proto-Oncogene Proteins / Protein Serine-Threonine Kinases / Cell Cycle Proteins / Protein Kinase Inhibitors / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Animals / Humans Language: En Year: 2016 Type: Article